Back to funds

SR ONE CAPITAL MANAGEMENT, LP

Updated 6 days ago

Managed by Sr One Capital Management, Lp • Latest filing Q3 2026

Portfolio value
$1.1B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$706.4M
Q1 2026$915.4M
Q2 2026$1B
Q3 2026$1.1B

Top holdings

17 positions as of Q3 2026

View filing
M

Veradermics, Inc.

Value
$252.2M
Shares
2.08M
% Port
21.94%
A

ADARx Pharmaceuticals, Inc.

Value
$198.1M
Shares
9.94M
% Port
17.24%
Z

Zenas BioPharma, Inc

Value
$135.9M
Shares
5.04M
% Port
11.82%
C

CRISPR Therapeutics AG

Value
$112.8M
Shares
2.04M
% Port
9.81%
A

Avalyn Pharma, Inc

Value
$94.3M
Shares
3.31M
% Port
8.20%
O

Odyssey Therapeutics, Inc.

Value
$84.3M
Shares
3.79M
% Port
7.34%
D

Design Therapeutics, Inc.

Value
$82M
Shares
6.53M
% Port
7.14%
O

ORIC Pharmaceuticals, Inc.

Value
$62.2M
Shares
4.62M
% Port
5.41%
M

Mineralys Therapeutics Inc.

Value
$39.3M
Shares
1.56M
% Port
3.42%
K

Korsana Biosciences, Inc.

Value
$19.6M
Shares
613.9K
% Port
1.71%
M

Mobia Medical, Inc

Value
$18.8M
Shares
1.99M
% Port
1.63%
S

ARS Pharmaceuticals, Inc.

Value
$17.3M
Shares
4.01M
% Port
1.50%
A

Alumis Inc.

Value
$14.5M
Shares
1.96M
% Port
1.26%
N

Nkarta, Inc.

Value
$8.7M
Shares
3.33M
% Port
0.76%
O

Oculis Holding AG

Value
$6M
Shares
641.0K
% Port
0.52%
R

Ultragenyx Pharmaceutical Inc.

Value
$2.1M
Shares
137.8K
% Port
0.18%
E

enGene Therapeutics Inc.

Value
$1.5M
Shares
747.8K
% Port
0.13%

Explore